Danaher's management continues to transform the conglomerate, and the GE Biopharma deal looks like an even better value after a recent disclosure.
News & Analysis: Danaher
The global science and technology company beat expectations in Q1. However, a pending acquisition caused Danaher to cut its full-year outlook.
DHR earnings call for the period ending March 29, 2019.
Here's how and why the best-performing stocks in the industrial-goods sector made headway in the last year, and what to expect in the future.
GE has been selling assets, and these three companies have been happy to buy.
A big day in biotech helped lift the market.
GE's CEO just had a bright idea about who to sell his healthcare unit to.
Stocks were generally higher due to favorable news on the trade front.
Looking at the bull and bear cases for the industrial company, which isn't really an industrial company anymore.
DHR earnings call for the period ending December 31, 2018.